Overview
Julie Rosser is a Laboratory Medicine provider in Denver, Colorado. Dr. Rosser has been practicing medicine for over 16 years. Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Waldenstrom Macroglobulinemia, and Acute Myeloid Leukemia (AML).
Her clinical research consists of co-authoring 4 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Year
Specialties
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
1719 E 19th Ave, Denver, CO 80218
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Children's Hospital Colorado
Nicholas Willard is a Laboratory Medicine provider in Aurora, Colorado. His top area of expertise is Gliomatosis Cerebri.
University Of Colorado Hospital
Francisco La Rosa is a Laboratory Medicine provider in Aurora, Colorado. Dr. La Rosa is highly rated in 1 condition, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Upper Tract Urothelial Carcinoma (UTUC).
Boulder Community Health
Parker Clement is a Laboratory Medicine provider in Boulder, Colorado. Dr. Clement is highly rated in 3 conditions, according to our data. His top areas of expertise are Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Relapsed Refractory Multiple Myeloma (RRMM), and Multiple Myeloma.
Frequently Asked Questions about Dr. Julie Rosser
How do I make an appointment with Dr. Julie Rosser?
You can book an appointment with Dr. Julie Rosser by calling their office at 720-754-6851. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Julie Rosser a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Julie Rosser is classified as an Experienced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Julie Rosser specialize in?
While Dr. Julie Rosser is a Laboratory Medicine, they have specific expertise in Multiple Myeloma, Smoldering Multiple Myeloma, and Waldenstrom Macroglobulinemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Laboratory Medicine.
Does Dr. Julie Rosser participate in research or clinical trials?
Yes. Dr. Julie Rosser has published 4 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Dr. Julie Rosser's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Rosser isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Rosser isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Anaplastic Large Cell LymphomaDr. Rosser isExperienced. Learn about Anaplastic Large Cell Lymphoma.
- Childhood Acute Myeloid LeukemiaDr. Rosser isExperienced. Learn about Childhood Acute Myeloid Leukemia.